- 18 Month Shelf Life
- Room temperature stable
- Provides a pH balanced environment
- Allow specimen to be stored in room temperature for 7 days without any change
Flocked Swab Features
- Ergonomic And Anatomic Design – For improved patient comfort and efficiency in cell specimen collection
- Increased Assay Sensitivity – Flocked Swabs are proven to elute >95% of the original sample rapidly thus easily resulting in improved assay sensitivity.
- Simply Collect, Snap And Ship – Peel open the pouch, collect the cell specimen and snap the applicator shaft into the Transport Medium or Cuvette-tube provided.
- Certified Free Of Inhibitors And Interference – Our flocked swabs are strictly sterilized and certified free of DNase, RNase and Human DNA and PCR inhibitors.
- Highly Suited To Automation – Sample eluted in liquid format finally is accessible to Liquid Based Microbiology and automation in the laboratories.
Cost-effective and multiple test:
- Enzyme Immuno Assays (EIA)
- Nucleic acid amplification assays
- 4M Guanidinium thiocyanate
- 25mM Sodium citrate, pH 5.2
- 2mM EDTA
- 0.2% Trion X-100
- 10% Ethanol
The Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic test is real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARSCoV-2 in upper and lower respiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) collected from individuals who meet 2019-nCoV clinical and/or epidemiological criteria. The SARS-CoV-2 test is not cleared, CLIA waived, approved, or subject to an approved investigational device exemption. CoreBioLabs is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high-complexity tests including SARS-CoV-2 molecular diagnostic test. All kits used in the SARS-CoV-2 test obtained Emergency Use Authorization (EUA) certificate from US FDA, and validated in the lab settings. This laboratory has established and verified the test’s accuracy, precision, reportable range, analytical specificity and sensitivity, as well as other relevant performance specifications.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Fault negative results may occur due to specimen quality, viral load, and interference in PCR reactions. Negative results must be combined with clinical observations, patient history, and epidemiological information.